Edition:
United States

Valeant Pharmaceuticals International Inc (VRX)

VRX on New York Consolidated

25.38USD
30 Sep 2016
Change (% chg)

$0.33 (+1.31%)
Prev Close
$25.05
Open
$25.15
Day's High
$25.44
Day's Low
$24.99
Volume
3,838,685
Avg. Vol
26,090,381
52-wk High
$182.64
52-wk Low
$18.55

VRX

Chart for VRX

About

Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment,... (more)

Overall

Beta: -0.13
Market Cap(Mil.): $8,555.09
Shares Outstanding(Mil.): 341.19
Dividend: --
Yield (%): --

Financials

  VRX Industry Sector
P/E (TTM): -- 36.90 36.83
EPS (TTM): -2.86 -- --
ROI: -2.26 14.48 13.93
ROE: -16.85 15.27 14.84

Valeant says discount program for heart drugs on track

Valeant Pharmaceuticals International Inc said its discount and rebates program for two high-priced heart drugs would cover over 90 percent U.S. hospitals once it had finalized the last of the 14 group purchasing organizations.

Sep 16 2016

Valeant says discount program for heart drugs on track

Sept 16 Valeant Pharmaceuticals International Inc said its discount and rebates program for two high-priced heart drugs would cover over 90 percent U.S. hospitals once it had finalized the last of the 14 group purchasing organizations.

Sep 16 2016

BRIEF-Valeant comments on discount and rebate program for Nitropress and Isuprel

Sept 16 Valeant Pharmaceuticals International Inc :

Sep 16 2016

Bill Miller: Valeant shares could post 25-30 percent returns over five years

NEW YORK Noted value investor Bill Miller said on Tuesday that Valeant Pharmaceuticals International Inc, the troubled Canadian drugmaker, is one of his top holdings, with the company's expected cash flows making the stock attractive.

Sep 13 2016

Bill Miller: Valeant shares could post 25-30 pct returns over 5 years

NEW YORK, Sept 13 Noted value investor Bill Miller said on Tuesday that Valeant Pharmaceuticals International Inc, the troubled Canadian drugmaker, is one of his top holdings, with the company's expected cash flows making the stock attractive.

Sep 13 2016

BRIEF-Eyegate says is eligible to get additional milestone payment from Valeant for EGP-437

Sept 12 Eyegate Receives Additional Milestone Payment From Valeant Pharmaceuticals For Egp

Sep 12 2016

U.S. Justice Department subpoenas Taro over generic drug pricing

WASHINGTON Taro Pharmaceutical Industries Ltd and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing, the company disclosed.

Sep 12 2016

U.S. Justice Department subpoenas Taro over generic drug pricing

WASHINGTON Taro Pharmaceutical Industries Ltd and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing, the company disclosed.

Sep 11 2016

UPDATE 1-U.S. Justice Department subpoenas Taro over generic drug pricing

WASHINGTON, Sept 11 Taro Pharmaceutical Industries Ltd and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing, the company disclosed.

Sep 11 2016

U.S. Justice Department subpoenas Taro over generic drug pricing

WASHINGTON, Sept 11 Taro Pharmaceutical Industries Ltd. and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing, the company disclosed late on Friday.

Sep 11 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.